News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dahan Michel
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/25/2023 |
4
| Dahan Michel (SVP, COO) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 200,000 shares
@ $0
Sold 95,478 shares
@ $1.2229, valued at
$116.8k
Granted 200,000 options to buy
@ $0.41, valued at
$82k
|
|
| 05/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/16/2023 |
4
| Dahan Michel (SVP, COO) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 200,000 shares
@ $0 |
|
| 03/03/2023 |
4
| Dahan Michel (SVP, COO) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 8,058 shares
@ $0.8775, valued at
$7.1k
Sold 10,476 shares
@ $0.8775, valued at
$9.2k
Sold 1,878 shares
@ $0.8775, valued at
$1.6k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2019 |
4
| Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Disposed/sold 11,909 shares
@ $7.7, valued at
$91.7k
|
|
| 03/05/2019 |
4
| Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 65,000 shares
@ $0
Granted 100,000 options to buy
@ $7.28, valued at
$728k
|
|
| 12/13/2018 |
4
| Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 23,385 shares
@ $8.94, valued at
$209.1k
|
|
| 03/02/2018 |
4
| Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 19,400 shares
@ $0
Granted 27,500 options to buy
@ $14.3, valued at
$393.3k
|
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/04/2017 |
4
| Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 1,401 shares
@ $9.1775, valued at
$12.9k
|
|
| 02/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/06/2016 |
4
| Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 1,402 shares
@ $7.4665, valued at
$10.5k
|
|
| 04/05/2016 |
4
| Dahan Michel (SVP, Chief Business Officer) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Sold 1,401 shares
@ $9.41, valued at
$13.2k
|
|
|
|